Inventor · disambiguated record
Kevin X. Chen
Also filed as: CHEN KEVIN · CHEN KEVIN X
55 granted patents·24 pending applications·1,169 citations·filing 2001–2025
98Inventor score
Files withSCHERING CORP17MEDSHINE DISCOVERY INC14GENENTECH INC9GUANGDONG RAYNOVENT BIOTECH CO LTD6DENDREON CORP4
Top patents by PatentIndex Score
79 records- 0197US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0296US7186747B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 6, 2007·47 cites·31 claims
- 0396US6911428B2Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Jun 28, 2005·124 cites·20 claims
- 0495US7592316B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2007·Granted Sep 22, 2009·34 cites·6 claims
- 0595US7425576B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Sep 16, 2008·20 cites·24 claims
- 0695US7205330B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2005·Granted Apr 17, 2007·54 cites·29 claims
- 0795US7173057B2Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virusSCHERING CORP·Filed 2005·Granted Feb 6, 2007·44 cites·29 claims
- 0895US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 0995US6846802B2Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moietiesSCHERING CORP·Filed 2001·Granted Jan 25, 2005·124 cites·21 claims
- 1094US12458647B2Macrocyclic derivative and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2025·Granted Nov 4, 2025·1 cites·30 claims
- 1194US9156872B22′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesGIRIJAVALLABHAN VINAY·Filed 2012·Granted Oct 13, 2015·45 cites·21 claims
- 1294US7423058B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2006·Granted Sep 9, 2008·15 cites·22 claims
- 1394US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 1494US6914122B2Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moietiesSCHERING CORP·Filed 2001·Granted Jul 5, 2005·89 cites·36 claims
- 1593US11725009B2Anti-influenza virus pyrimidine derivativeGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2021·Granted Aug 15, 2023·2 cites·17 claims
- 1693US7192957B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 20, 2007·28 cites·28 claims
- 1792US9763922B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2015·Granted Sep 19, 2017·9 cites·20 claims
- 1892US6894072B2Compounds as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2003·Granted May 17, 2005·59 cites·25 claims
- 1990US11535613B2Crystal form and salt form of pyridoimidazole compound and preparation method thereforGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2019·Granted Dec 27, 2022·6 cites·25 claims
- 2090US9408863B25′-substituted nucleoside analogs and methods of use thereof for the treatment of viral diseasesVERMA VISHAL A·Filed 2012·Granted Aug 9, 2016·13 cites·12 claims
- 2189US11136319B2Anti-influenza virus pyrimidine derivativeGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2017·Granted Oct 5, 2021·4 cites·19 claims
- 2289USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 2384US8557848B24,5-ring annulated indole derivatives for treating or preventing of HCV and related viral infectionsCHEN KEVIN X·Filed 2007·Granted Oct 15, 2013·10 cites·13 claims
- 2483US11247989B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2018·Granted Feb 15, 2022·2 cites·8 claims
- 2583US10206931B2Therapeutic compounds and uses thereofGENENTECH INC·Filed 2017·Granted Feb 19, 2019·5 cites·17 claims
- 2683US8067379B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseBENNETT FRANK·Filed 2005·Granted Nov 29, 2011·8 cites·43 claims
- 2783US7449447B2Peptidomimetic NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2004·Granted Nov 11, 2008·20 cites·41 claims
- 2882US12319692B2Anti-influenza virus pyrimidine derivativesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2023·Granted Jun 3, 2025·0 cites·17 claims
- 2982US8772505B2Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis CCHEN KEVIN X·Filed 2010·Granted Jul 8, 2014·8 cites·14 claims
- 3082US7619094B2Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virusSCHERING CORP·Filed 2006·Granted Nov 17, 2009·5 cites·33 claims
- 3181US9139569B2Fused tricyclic aryl compounds useful for the treatment of viral diseasesROSENBLUM STUART B·Filed 2010·Granted Sep 22, 2015·9 cites·12 claims
- 3280US10010549B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2015·Granted Jul 3, 2018·2 cites·10 claims
- 3380US9365583B2Substituted pyrazoles and uses thereofGENENTECH INC·Filed 2014·Granted Jun 14, 2016·3 cites·40 claims
- 3480US8980920B2Antiviral compounds of three linked aryl moieties to treat diseases such as hepatitis CZENG QINGBEI·Filed 2010·Granted Mar 17, 2015·8 cites·8 claims
- 3579US2025250275A1Anti-influenza virus pyrimidine derivativesGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2025·Application pending·0 cites
- 3678US11117899B2[1,2,4]triazolo[1,5-c]pyrimidine derivative as A2A receptor inhibitorMEDSHINE DISCOVERY INC·Filed 2018·Granted Sep 14, 2021·3 cites·23 claims
- 3774US11377444B2Pyridopyrimidine compounds acting as mTORC 1/2 dual inhibitorsMEDSHINE DISCOVERY INC·Filed 2018·Granted Jul 5, 2022·1 cites·20 claims
- 3873US11129832B2Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2019·Granted Sep 28, 2021·0 cites·27 claims
- 3973US11014943B2Azetidine derivativeCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted May 25, 2021·1 cites·20 claims
- 4073US9796705B2Fused tricyclic compounds and methods of use thereof for the treatment of viral diseasesMERCK SHARP & DOHME·Filed 2016·Granted Oct 24, 2017·1 cites·7 claims
- 4172US11312715B2Fused ring derivative as A2A receptor inhibitorCSTONE PHARMACEUTICALS SUZHOU CO LTD·Filed 2018·Granted Apr 26, 2022·2 cites·18 claims
- 4271US8143305B22,3-substituted indole derivatives for treating viral infectionsANILKUMAR GOPINADHAN N·Filed 2008·Granted Mar 27, 2012·2 cites·12 claims
- 4364US2018133219A1Biheteroaryl compounds and uses thereofGENENTECH INC·Filed 2018·Application pending·0 cites
- 4464US2022127265A1Therapeutic compounds and uses thereofGENENTECH INC·Filed 2022·Application pending·0 cites
- 4564US2025268907A1Macrocyclic derivative and use thereofGUANGZHOU JOYO PHARMATECH CO LTD·Filed 2025·Application pending·0 cites
- 4660US2024287043A1Ketoamide derivative and application thereofGUANGDONG RAYNOVENT BIOTECH CO LTD·Filed 2022·Application pending·0 cites
- 4758US7718691B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted May 18, 2010·0 cites·33 claims
- 4857US2006205672A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2005·Application pending·0 cites
- 4956US7759499B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Jul 20, 2010·0 cites·22 claims
- 5056US2024158413A1Fused polycyclic substituted 5-carboxylic acid thienopyrimidine dione compound and use thereofSOTER BIOPHARMA PTE LTD·Filed 2022·Application pending·0 cites
Showing the top 50 of 79 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Kevin X. Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →